Hepatitis C virus and end stage renal disease

被引：0
作者：
Gutierrez J.A. [1 ]
Patton H.M. [2 ]
机构：
[1] Division of Gastroenterology, University of California, San Diego, CA 92093, San Diego, 9500 Gilman Drive
[2] Division of Gastroenterology, University of California, San Diego, CA 92093, San Diego, 9500 Gilman Drive
来源：
Current Hepatitis Reports | 2011年 / 10卷 / 3期
关键词：
Chronic kidney disease; End stage renal disease; Hemodialysis; Hepatitis C virus;
D O I：
10.1007/s11901-011-0104-4
中图分类号：
学科分类号：
摘要：
Hepatitis C virus (HCV) is one of the leading causes of chronic liver disease in the world. It is particularly common in patients with end-stage renal disease (ESRD), both due to risk for chronic kidney disease related to HCV infection and risk for HCV infection acquisition in the hemodialysis population. In the United States, nosocomial risk of HCV has diminished, but this continues to be a major challenge in the developing world. Current available HCV therapies are more complex and less efficacious in the setting of ESRD. In the setting of donor organ shortage, transplant specialists must weigh the risks and benefits of using donor kidneys from patients positive for HCVantibody. The goal of this review is to update the reader on significant findings in HCV and ESRD. The major topics covered include updates in epidemiology, natural history, HCV treatment, and transplantation. © Springer Science+Business Media, LLC 2011.
引用
收藏
页码：196 / 203
页数：7
相关论文
共 75 条
[1]  
Lavanchy D., The global burden of hepatitis C, Liver Int., 29, SUPPL. 1, pp. 74-81, (2009)
[2]  
Thompson N.D., Hellinger W.C., Kay R.S., Et al., Healthcare-associated hepatitis C virus transmission among patients in an abdominal organ transplant center, Transpl Infect Dis., 11, pp. 324-329, (2009)
[3]  
Thompson N.D., Novak R.T., Datta D., Et al., Hepatitis C virus transmission in hemodialysis units: Importance of infection control practices and aseptic technique, Infect Control Hosp Epidemiol., 30, pp. 900-903, (2009)
[4]  
Thompson N.D., Perz J.F., Moorman A.C., Holmberg S.D., Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008, Ann Intern Med., 150, pp. 33-39, (2009)
[5]  
Evaluation of acute hepatitis C infection surveillance-United States, 2008, MMWR Morb Mortal Wkly Rep., 59, pp. 1407-1410, (2010)
[6]  
Hepatitis C virus transmission at an outpatient hemodialysis unit-New York, 2001-2008, MMWR Morb Mortal Wkly Rep., 58, pp. 189-194, (2009)
[7]  
Afifi A., Abdel-Mohsen W., Hepatitis C virus infection among hemodialysis patients in developing countries
[8]  
a major health problem, UNINET, 5, (2009)
[9]  
Santoro D., Mazzaglia G., Savica V., Li Vecchi M., Bellinghieri G., Hepatitis status and mortality in hemodialysis population, Ren Fail., 31, pp. 6-12, (2009)
[10]  
Trevizoli J.E., De Paula Menezes R., Ribeiro Velasco L.F., Et al., Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients, Clin J Am Soc Nephrol., 3, pp. 1385-1390, (2008)
12345678